Matthew F. Mescher
#166,287
Most Influential Person Now
Matthew F. Mescher's AcademicInfluence.com Rankings
Matthew F. Mescherbiology Degrees
Biology
#13491
World Rank
#17037
Historical Rank
Immunology
#932
World Rank
#956
Historical Rank

Download Badge
Biology
Why Is Matthew F. Mescher Influential?
(Suggest an Edit or Addition)Matthew F. Mescher's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Inflammatory cytokines provide a third signal for activation of naive CD4+ and CD8+ T cells. (1999) (677)
- Signals required for programming effector and memory development by CD8+ T cells (2006) (638)
- Cutting Edge: Type I IFNs Provide a Third Signal to CD8 T Cells to Stimulate Clonal Expansion and Differentiation1 (2005) (599)
- Inflammatory cytokines as a third signal for T cell activation. (2010) (503)
- Signal 3 Determines Tolerance versus Full Activation of Naive CD8 T Cells (2003) (429)
- CTLA-4 blockade reverses CD8+ T cell tolerance to tumor by a CD4+ T cell- and IL-2-dependent mechanism. (1999) (332)
- Purification and characterization of a prokaryotic glycoprotein from the cell envelope of Halobacterium salinarium. (1976) (259)
- Programming for CD8 T Cell Memory Development Requires IL-12 or Type I IFN1 (2009) (238)
- The Roles of IL-12 in Providing a Third Signal for Clonal Expansion of Naive CD8 T Cells1 (2002) (221)
- CD8 T Cell Clonal Expansion and Development of Effector Function Require Prolonged Exposure to Antigen, Costimulation, and Signal 3 Cytokine 1 (2003) (195)
- Cytotoxic T lymphocyte mediated lysis without release of serine esterase (1987) (191)
- Control of syngeneic tumor growth by activation of CD8+ T cells: efficacy is limited by migration away from the site and induction of nonresponsiveness. (1999) (188)
- CD8+ T cells become nonresponsive (anergic) following activation in the presence of costimulation. (1999) (181)
- CD8+ memory T cells (CD44high, Ly-6C+) are more sensitive than naive cells to (CD44low, Ly-6C-) to TCR/CD8 signaling in response to antigen. (1998) (181)
- Adjuvant effect of IL-12: conversion of peptide antigen administration from tolerizing to immunizing for CD8+ T cells in vivo. (1999) (178)
- Actin-containing matrix associated with the plasma membrane of murine tumour and lymphoid cells (1981) (172)
- The autoimmunity-associated gene PTPN22 potentiates toll-like receptor-driven, type 1 interferon-dependent immunity. (2013) (168)
- ICAM‐1 and B7‐1 provide similar but distinct costimulation for CD8+ T cells, while CD4+ T cells are poorly costimulated by ICAM‐1 (1999) (153)
- Peptide Antigen Priming of Naive, But Not Memory, CD8 T Cells Requires a Third Signal That Can Be Provided by IL-121 (2002) (139)
- IL-12 Enhances CD8 T Cell Homeostatic Expansion1 (2001) (136)
- Activated CD8 binding to class I protein mediated by the T-cell receptor results in signalling (1990) (133)
- IL-21 Promotes Differentiation of Naive CD8 T Cells to a Unique Effector Phenotype1 (2007) (133)
- Alloreactive T cells discriminate among a diverse set of endogenous peptides. (1991) (132)
- Gene Regulation and Chromatin Remodeling by IL-12 and Type I IFN in Programming for CD8 T Cell Effector Function and Memory1 (2009) (129)
- The roles of CD8 in cytotoxic T lymphocyte function. (1993) (127)
- Detuning CD8 T cells: down-regulation of CD8 expression, tetramer binding, and response during CTL activation (2007) (126)
- Structural (shape-maintaining) role of the cell surface glycoprotein of Halobacterium salinarium. (1976) (123)
- Surface contact requirements for activation of cytotoxic T lymphocytes. (1992) (120)
- Qualitative differences between naive and memory T cells make a major contribution to the more rapid and efficient memory CD8+ T cell response. (1998) (116)
- Cutting Edge: Bcl-3 Up-Regulation by Signal 3 Cytokine (IL-12) Prolongs Survival of Antigen-Activated CD8 T Cells1 (2005) (116)
- Activation-Induced Nonresponsiveness: A Th-Dependent Regulatory Checkpoint in the CTL Response1 (2002) (106)
- Signaling pathways activated by leukocyte function-associated Ag-1-dependent costimulation. (1999) (105)
- Signal 3 Tolerant CD8 T Cells Degranulate in Response to Antigen but Lack Granzyme B to Mediate Cytolysis1 (2005) (102)
- CD4 T Cell-Dependent Conditioning of Dendritic Cells to Produce IL-12 Results in CD8-Mediated Graft Rejection and Avoidance of Tolerance (2005) (97)
- Cytotoxic T-lymphocyte activation involves a cascade of signalling and adhesion events (1992) (96)
- Protein and Carbohydrate Composition of the Cell Envelope of Halobacterium salinarium (1974) (92)
- B7‐1‐dependent co‐stimulation results in qualitatively and quantitatively different responses by CD4+ and CD8+ T cells (1997) (90)
- Characterization of an anti-H-2 monoclonal antibody and its use in large-scale antigen purification. (1981) (85)
- Opposing Effects of IL-2 in Tumor Immunotherapy: Promoting CD8 T Cell Growth and Inducing Apoptosis1 (2002) (74)
- Enhancement of T-cell–Mediated Antitumor Response: Angiostatic Adjuvant to Immunotherapy against Cancer (2011) (73)
- Cutting Edge: IL-12 and Type I IFN Differentially Program CD8 T Cells for Programmed Death 1 Re-expression Levels and Tumor Control (2013) (73)
- Molecular interactions required for triggering alloantigen-specific cytolytic T lymphocytes. (1989) (72)
- Signal 3 Availability Limits the CD8 T Cell Response to a Solid Tumor1 (2007) (72)
- Defective MHC Class II Presentation by Dendritic Cells Limits CD4 T Cell Help for Antitumor CD8 T Cell Responses1 (2008) (71)
- Purification of the H-2Kk molecule of the murine major histocompatibility complex. (1979) (69)
- Autocrine IFN-γ Promotes Naive CD8 T Cell Differentiation and Synergizes with IFN-α To Stimulate Strong Function (2012) (67)
- The induction of virus-specific cytotoxic T lymphocytes with solubilized viral and membrane proteins (1978) (67)
- Induction of secondary cytotoxic T lymphocytes by purified HLA-A and HLA-B antigens reconstituted into phospholipid vesicles. (1978) (65)
- The Adjuvant Effects of Mycobacterium tuberculosis Heat Shock Protein 70 Result from the Rapid and Prolonged Activation of Antigen-Specific CD8+ T Cells In Vivo1 (2002) (62)
- Migration and activation of antigen-specific CD8+ T cells upon in vivo stimulation with allogeneic tumor. (1997) (61)
- Artificial cell surface constructs for studying receptor-ligand contributions to lymphocyte activation. (1997) (58)
- Molecular Interactions in the Activation of Effector and Precursor Cytotoxic T Lymphocytes (1995) (57)
- Antigen-presenting cell function in induction of helper T cells for cytotoxic T-lymphocyte responses: evidence for antigen processing. (1981) (56)
- Cytotoxic T cell activation by class I protein on cell-size artificial membranes: antigen density and Lyt-2/3 function. (1987) (53)
- Cellular interactions in the generation of cytolytic T lymphocyte responses: role of Ia-positive splenic adherent cells in presentation in H-2 antigen. (1980) (53)
- ICAM-1–Dependent Homotypic Aggregates Regulate CD8 T Cell Effector Function and Differentiation during T Cell Activation (2013) (53)
- Activation of CD8-dependent cytotoxic T lymphocyte adhesion and degranulation by peptide class I antigen complexes. (1993) (52)
- In Vivo Augmentation of Tumor-Specific CTL Responses by Class I/Peptide Antigen Complexes on Microspheres (Large Multivalent Immunogen)1 (2003) (52)
- Signaling Alterations in Activation-Induced Nonresponsive CD8 T Cells1 (2001) (51)
- Molecular basis for checkpoints in the CD8 T cell response: tolerance versus activation. (2007) (51)
- Short term exposure to cis unsaturated free fatty acids inhibits degranulation of cytotoxic T lymphocytes. (1990) (50)
- Activation-induced non-responsiveness (anergy) limits CD8 T cell responses to tumors. (2007) (50)
- Contribution of lymphocyte function-associated-1/intercellular adhesion molecule-1 binding to the adhesion/signaling cascade of cytotoxic T lymphocyte activation (1994) (50)
- Secondary cytolytic T lymphocyte stimulation by purified H-2Kk in liposomes. (1981) (49)
- Cellular interactions in the generation of cytolytic T lymphocyte responses Analysis of the helper T cell pathway (1981) (49)
- Activation of antigen-specific T cells by artificial cell constructs having immobilized multimeric peptide-class I complexes and recombinant B7-Fc proteins. (2001) (48)
- Activation of polyphosphoinositide hydrolysis in T cells by H-2 alloantigen but not MLS determinants. (1990) (48)
- Artificial antigen-presenting constructs efficiently stimulate minor histocompatibility antigen-specific cytotoxic T lymphocytes. (2004) (44)
- The thymus leukemia antigen binds human and mouse CD8 (1991) (44)
- The Poststimulation Program of CD4 Versus CD8 T Cells (Death Versus Activation-Induced Nonresponsiveness)1 (2002) (43)
- Cytoskeletal function in CD8- and T cell receptor-mediated interaction of cytotoxic T lymphocytes with class I protein (1991) (41)
- Glycosylation of the surface glycoprotein of Halobacterium salinarium via a cyclic pathway of lipid‐linked intermediates (1978) (41)
- LFA-1-Mediated Costimulation of CD8+ T Cell Proliferation Requires Phosphatidylinositol 3-Kinase Activity1 (2001) (40)
- Cytolytic T-lymphocyte response to isolated class I H2 proteins and influenza peptides (1989) (39)
- Formation of lipid-linked sugar compounds in Halobacterium salinarium. Presumed intermediates in glycoprotein synthesis. (1976) (39)
- Solid-phase binding of class I and II MHC proteins: immunoassay and T cell recognition. (1989) (37)
- Extensive polymorphism surrounding the murine Ia A beta chain gene. (1983) (36)
- Phase I Trial of Large Multivalent Immunogen Derived from Melanoma Lysates in Patients with Disseminated Melanoma (2004) (32)
- Antigen Processing and MHC-II Presentation by Dermal and Tumor-Infiltrating Dendritic Cells1 (2009) (30)
- Analysis of the two-signal requirement for precursor cytolytic T lymphocyte activation using H-2Kk in liposomes. (1982) (30)
- Purification of murine MHC antigens by monoclonal antibody affinity chromatography. (1983) (29)
- Autologous Large Multivalent Immunogen Vaccine in Patients With Metastatic Melanoma and Renal Cell Carcinoma (2008) (29)
- Triton X-100 extraction of P815 tumor cells: evidence for a plasma membrane skeleton structure (1985) (28)
- Cell-sized, supported artificial membranes (pseudocytes): response of precursor cytotoxic T lymphocytes to class I MHC proteins. (1986) (27)
- CD8 Memory T Cells (CD44, Ly-6C) Are More Sensitive than Naive Cells (CD44, Ly-6C) to TCR/CD8 Signaling in Response to Antigen (1998) (27)
- Carbohydrate moieties of major histocompatibility complex class I alloantigens are not required for their recognition by T lymphocytes (1985) (26)
- Exogenous β2‐microglobulin is required for antigenic peptide binding to isolated class I major histocompatibility complex molecules (1991) (26)
- Glycoproteins as cell-surface structural components (1981) (26)
- Antigen Controls IL-7Rα Expression Levels on CD8 T Cells during Full Activation or Tolerance Induction1 (2008) (25)
- T cell receptor and CD8‐dependent tyrosine phosphorylation events in cytotoxic T lymphocytes: activation of p56lck by CD8 binding to class I protein (1996) (25)
- The induction of secondary cytolytic T lymphocytes by solubilized membrane proteins (1978) (25)
- Augmentation of in vivo cytotoxic T lymphocyte activity and reduction of tumor growth by large multivalent immunogen. (1992) (24)
- Kinetics of cytolytic T lymphocyte binding to target cells in suspension. (1981) (24)
- Bacitracin induces sphere formation in Halobacterium species which lack a wall peptidoglycan. (1975) (24)
- Analysis of antigen presentation by metabolically inactive accessory cells and their isolated membranes. (1985) (23)
- T cell receptor-mediated signaling occurs in the absence of inositol phosphate production. (1988) (23)
- Phosphatidylinositol 3 kinase activity is not essential for B7-1-mediated costimulation of proliferation or development of cytotoxicity in murine T cells. (1996) (22)
- Specific reversal of cytolytic T cell-target cell functional binding is induced by free target cells. (1981) (22)
- Large-scale purification of murine I-Ak and I-Ek antigens and characterization of the purified proteins. (1983) (22)
- The CD8 T cell response to vaccinia virus exhibits site-dependent heterogeneity of functional responses. (2007) (22)
- Immunotherapy of established murine tumors with large multivalent immunogen and cyclophosphamide. (1996) (21)
- The requirements for antigen multivalency in class I antigen recognition and triggering of primed precursor cytolytic T lymphocytes. (1986) (20)
- Agorins: major structural proteins of the plasma membrane skeleton of P815 tumor cells (1986) (20)
- Signals for activation of CD8-dependent adhesion and costimulation in CTLs. (1994) (20)
- Growth-inhibitory activity of lymphoid cell plasma membranes. I. Inhibition of lymphocyte and lymphoid tumor cell growth (1984) (20)
- Inhibition of lymphoid cell growth by a lipid-like component of macrophage hybridoma cells. (1986) (19)
- Cytotoxic T‐lymphocyte interaction with fibronectin and vitronectin: activated adhesion and cosignalling (1997) (17)
- Antigen Processing and MHC-II Presentation by Dermal and Tumor-Infiltrating Dendritic Cells (2009) (17)
- Growth-inhibitory activity of lymphoid cell plasma membranes. II. Partial characterization of the inhibitor (1984) (17)
- Hairpin configuration of H-2Kk in liposomes formed by detergent dialysis. (1984) (16)
- Class I alloantigen is sufficient for cytolytic T lymphocyte binding and transmembrane signaling (1988) (15)
- Equilibrium binding of cytotoxic T lymphocytes to class I antigen. (1991) (15)
- T cell recognition of nonpolymorphic determinants on H-2 class I molecules. (1988) (15)
- Stimulation of tumor-specific immunity using tumor cell plasma membrane antigen. (1997) (14)
- Lymphocyte recognition of H-2 antigen in liposomes. (1981) (13)
- Role of I-region gene products in T cell activation. I. Stimulation of T lymphocyte proliferative responses by subcellular membrane preparations containing Ia alloantigens. (1982) (13)
- Adoptive T Cell Therapy with IL-12–Preconditioned Low-Avidity T Cells Prevents Exhaustion and Results in Enhanced T Cell Activation, Enhanced Tumor Clearance, and Decreased Risk for Autoimmunity (2020) (13)
- Evolutionarily conserved resistance to phagocytosis observed in melanoma cells is insensitive to upregulation of pro-phagocytic signals and to CD47 blockade (2019) (11)
- The plasma membrane 'skeleton' of tumor and lymphoid cells: a role in cell lysis? (1985) (11)
- Inhibition of the induction of cytolytic T lymphocytes with alloantisera directed against H-2K and H-2D gene products. (1978) (11)
- Antigen recognition by T cells. Quantitative effects of augmentation by antibodies providing accessory interactions. (1990) (11)
- Cell-mediated immunity to viral glycoproteins. (1980) (11)
- Cytolytic T lymphocyte recognition of subcellular antigen. (1982) (10)
- IgE receptor-mediated arachidonic acid release by rat basophilic leukemia (RBL-2H3) cells: possible role in activating degranulation. (1992) (10)
- Murine Cell Surface Immunoglobulin: Two Forms of δ-Heavy Chain (1979) (9)
- Proteolytic modifications of the carboxyl-terminal region of H-2Kk. (1982) (8)
- T-cell receptor-activated adhesion systems. (1990) (8)
- Induction of allogeneic cytolytic T lymphocytes by partially purified membrane glycoproteins. (1980) (8)
- Murine cell surface immunoglobulin: two native IgD structures. (1980) (7)
- Genetic control of murine IgD structural heterogeneity. (1980) (7)
- CD8 and antigen-specific T cell adhesion cascades. (1993) (7)
- IL-12 Memory , CD 8 T Cells Requires a Third Peptide Antigen Priming of Naive , But Not (2002) (7)
- The ability of Ia and H‐2Kk‐bearing membranes to replace the antigen‐presenting cell in an H‐2Kkallogeneic cytotoxic T cell response (1985) (7)
- Stimulation of secondary anti-MSV cytolytic T lymphocytes with MBL-2 reconstituted membranes. (1983) (6)
- Inhibition of normal lymphocyte responses by cell membranes. (1984) (6)
- The Interaction of MHC Antigens with the Plasma Membrane and the Other Cellular Components (1982) (6)
- Activated adhesion of CTL to MHC class I but not to fibronectin is inhibited by cis unsaturated fatty acids and phenylarsine oxide. (1995) (6)
- Role of phosphoinositide 3‐kinase in TCR‐signaled regulation of CD8‐mediated adhesion to class I MHC protein (2001) (6)
- Specific reversal of cytolytic T lymphocyte--target cell interaction. (1981) (5)
- The induction of cytolytic T lymphocytes with syngeneic trinitrophenyl-coupled membranes. (1979) (4)
- Murine cell surface immunoglobulin: two forms of delta-heavy chain. (1979) (4)
- Cytolytic T lymphocyte mediated chromium-51 release versus spontaneous release from blast and spleen cell targets at low temperatures. (1981) (3)
- The Thymus Leukemia Antigen Binds Human and Mouse CD 8 By (2003) (3)
- Th-Dependent Regulatory Checkpoint in the Activation-Induced Nonresponsiveness: A (2002) (3)
- Antitumor CD 8 T Cell Responses Dendritic Cells Limits CD 4 T Cell Help for Defective MHC Class II Presentation by (2008) (3)
- Presence of Costimulation ( Anergic ) Following Activation in the T Cells Become Nonresponsive + CD 8 (1999) (2)
- Adjuvants and the Initiation of T-Cell Responses (2006) (2)
- INDUCTION OF VIRUS-SPECIFIC H-2 RESTRICTED MURINE CTL BY LIPOSOMES (1979) (2)
- Phosphatidylinositol 3-Kinase Activity Cell Proliferation Requires T + LFA-1-Mediated Costimulation of CD 8 (2001) (1)
- Cellular interactions in the regulation of the cytolytic T-lymphocyte response: the effect of suboptimal antigen dose. (1981) (1)
- Plasma membrane matrix of murine tumor cells (1984) (1)
- Maintaining protection against invasive bacteria with protein- polysaccharide conjugate vaccines (2009) (1)
- CTL Recognition of Purified MHC Antigens and Other Cell Surface Ligands (1993) (1)
- The shape-maintaining component of halobacterium salinarium: a cell surface glycoprotein. (1977) (1)
- Avoidance of Tolerance CD8-Mediated Graft Rejection and Dendritic Cells to Produce IL-12 Results in CD4 T Cell-Dependent Conditioning of (2005) (0)
- The use of purified H-2 antigens to define the helper T cell pathway involved in cytolytic T lymphocyte induction (1980) (0)
- CellsSignal for Clonal Expansion of Naive CD8 T The Roles of IL-12 in Providing a Third (2002) (0)
- Antigen processing and MHC-II presentation by dermal and tumor infiltrating Dendritic Cells (78.26) (2009) (0)
- T Cells to a Unique Effector Phenotype IL-21 Promotes Differentiation of Naive CD8 (2007) (0)
- Structural and functional analysis of T cell responses to Ia antigens (1984) (0)
- T the More Rapid and Efficient Memory CD8 Memory T Cells Make a Major Contribution to Qualitative Differences Between Naive and (1998) (0)
- Differentiation during T Cell Activation Regulate CD8 T Cell Effector Function and Dependent Homotypic Aggregates - ICAM-1 (2013) (0)
- Carbohydrate moieties of H-2K(k) class I alloantigens are not required for their recognition by precursor CTL (1985) (0)
- Surface Carbohydrates of the Prokaryotic Cell, I.W. Sutherland (Ed.). Academic Press, Chichester, New York, Brisbane and Toronto (1977), ISBN: 0 12 677850 7 (1978) (0)
- CD8 T Cell Effector Function and Memory for by IL-12 and Type I IFN in Programming Gene Regulation and Chromatin Remodeling (2009) (0)
- CostimulationFunction-Associated Ag-1-Dependent Signaling Pathways Activated by Leukocyte (1999) (0)
- Abstract A65: Mechanisms of melanoma cell resistance to phagocytosis (2017) (0)
- This information is current as To Stimulate Strong Function α Differentiation and Synergizes with IFN-Promotes Naive CD 8 T Cell γ Autocrine IFN - (2012) (0)
- Purification and Characterization of a Prokaryotic Glycoprotein from the Cell Envelope of HaLobacterium saZinarium (2002) (0)
- Nonresponsive CD 8 T Cells Signaling Alterations in Activation-Induced Ee (2001) (0)
- Programming for a CD8 T Cell Memory Response Requires IL-12 and/or Type I IFN (95.23) (2007) (0)
- Nonresponsive CD8 T Cells Signaling Alterations in Activation-Induced (2001) (0)
- Valuable … interesting … stimulating (1978) (0)
- T Cells + and CD 8 + Signal for Activation of Naive CD 4 Inflammatory Cytokines Provide a Third (1999) (0)
- The Role of CD8-Class I Interactions in CTL Function (1993) (0)
- Antigen-Activated CD8 T Cells 3 Cytokine (IL-12) Prolongs Survival of Cutting Edge: Bcl-3 Up-Regulation by Signal (2004) (0)
- Dendritic cell tumor‐antigen processing and activation of tumor‐specific T cells (2008) (0)
- Activation-Induced Nonresponsiveness ) CD 8 T Cells ( Death Versus The Poststimulation Program of CD 4 Versus (2002) (0)
- In Vivo T Cells + Tolerizing to Immunizing for CD8 Peptide Antigen Administration from Adjuvant Effect of IL-12: Conversion of (1999) (0)
- Cellsby Dermal and Tumor-Infiltrating Dendritic Antigen Processing and MHC-II Presentation (2009) (0)
- Allogeneic cytolytic t lymphocyte stimulation by purified h-2kk in liposomes. Abstr. (1980) (0)
- Antigen-Specific CD 8 from the Rapid and Prolonged Activation of Heat Shock Protein 70 Result tuberculosis Mycobacterium The Adjuvant Effects of (2002) (0)
- Artificial antigen-presenting Cells: Large multivalent immunogens (2012) (0)
- Autocrine IFN-gamma promotes limited differentiation of naïve CD8 T cells and synergizes with Type I IFN to stimulate optimal effector functions (110.5) (2012) (0)
- (reconstituted membrane vesicles/plasma membrane matrix/matrix-containing liposomes) (2016) (0)
- Extensive Restriction Site Polymorphism Surrounding a Single Copy I-Aβ Gene (1983) (0)
- Abstract 4082: CD47 blockade to enhance adaptive anti-tumor immune responses (2014) (0)
- Expansion and Differentiation Signal to CD8 T Cells to Stimulate Clonal Cutting Edge: Type I IFNs Provide a Third (2005) (0)
- Abstract A143: Melanoma cell resistance to phagocytosis is unrelated to expression of conventional “eat-me/don't eat-me” signals (2016) (0)
- Structural heterogeneity of murine IgD during ontogeny. (1982) (0)
- MURINE IgD IS STRUCTURALLY HETEROGENEOUS WHEN IT FIRST APPEARS DURING ONTOGENY (1982) (0)
- IL-12 and Type I IFN differentially program CD8 T cells for PD-1 expression levels and tumor control (127.32) (2012) (0)
- Development Requires IL-12 or Type I IFN Programming for CD 8 T Cell Memory (2009) (0)
- Costimulation, and Signal 3 Cytokine Prolonged Exposure to Antigen, Development of Effector Function Require CD8 T Cell Clonal Expansion and (2003) (0)
- Abstract A051: Melanoma displays an evolutionarily conserved resistance to upregulation of prophagocytic signals and to CD47 blockade (2019) (0)
- Session V: Strategies for immunization - Large Multivalent Immunogen (LMI) immunotherapy (2003) (0)
- Immunotherapy: Promoting CD8 T Cell Opposing Effects of IL-2 in Tumor (2002) (0)
- Multivalent Immunogen ) Complexes on Microspheres ( Large CTL Responses by Class I / Peptide Antigen In Vivo Augmentation of Tumor-Specific (2002) (0)
- Cellsfor Clonal Expansion of Naive CD8 T The Roles of IL-12 in Providing a Third (2017) (0)
- and Tumor Control Programmed Death 1 Re-expression Levels Differentially Program CD8 T Cells for Cutting Edge: IL-12 and Type I IFN (2013) (0)
- Cytolysis toResponse to Antigen but Lack Granzyme B Signal 3 Tolerant CD 8 T Cells Degranulate in (2005) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Matthew F. Mescher?
Matthew F. Mescher is affiliated with the following schools: